Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
As Tecentriqs following indication may become a postoperative adjuvant therapy for early non-small cell lung cancer (NSCLC), Roche has to prepare for increased Tecentriq use in a large number of lung cancer patients
10.1172/JCI38940 15 ChangC.WorleyB
Besides, the crude AF/Aflutter counts were small (13 events in each arm), raising concerns about instability of estimates, and confidence intervals appear narrow
Sutapa Ghosh
US$ 27.37
US$ 23.97
US$ 24.36
US$ 28.01
US$ 20.24
US$ 22.14
US$ 20.27
US$ 29.70
US$ 25.89
US$ 24.45
